| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/08/2008 | US20080107621 Use Of Il - 6 In Microvascular Complicaitions |
| 05/08/2008 | US20080107620 Human Cytomegalovirus Immunotherapy |
| 05/08/2008 | US20080107613 Pharmaceutical composition comprising a macrolide t-cell immunomodulator and anti-photoaging agent |
| 05/08/2008 | US20080107605 From a clone comprising complete nucleotide sequence for the expression of the TSH |
| 05/08/2008 | US20080107604 Method for the Prediction of the Risk Potential for Cancerous Diseases and Inflammatory Intestinal Diseases and Corresponding Tests |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |
| 05/08/2008 | US20080105961 Ligands of the Molecule Fit (Agt-121) and their Pharmaceutical Use |
| 05/08/2008 | US20080105546 Electrohydrodynamic method for processing liquids using electric fields without denaturing biological material or sensitive molecules, and thus benefits from producing comminutes with controlled diameter and charge |
| 05/08/2008 | DE20221790U1 Koagulationsaktives Antithrombin III und dessen Verwendung zur Prophylaxe und Therapie von Angiogenese-abhängigen Erkrankungen Koagulationsaktives antithrombin III and its use for the prophylaxis and therapy of angiogenesis-dependent diseases |
| 05/08/2008 | DE102006052560A1 Anti-diabetogene Calcium-Peptid-Zusammensetzung Anti-diabetogenic calcium peptide composition |
| 05/08/2008 | CA2671310A1 Bead based receptor biology |
| 05/08/2008 | CA2668292A1 Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor |
| 05/08/2008 | CA2667856A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | CA2667841A1 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 05/08/2008 | CA2667178A1 Agent comprising g-csf for prevention and treatment of diabetic peripheral neuropathy |
| 05/08/2008 | CA2664304A1 Use of pegylated il-10 to treat cancer |
| 05/08/2008 | CA2657319A1 Mg53 compositions and methods of use |
| 05/08/2008 | CA2644670A1 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918380A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918373A1 Anti-obesity agent and anti-obesity food |
| 05/07/2008 | EP1918371A1 Novel phospholipid processing agent |
| 05/07/2008 | EP1918300A2 Peptide-based immunization therapy for treatment of atherosclerosis |
| 05/07/2008 | EP1918299A1 Modulators of cell adhesion molecules and use thereof |
| 05/07/2008 | EP1918298A2 Peptide |
| 05/07/2008 | EP1918297A1 Neuronal differentiation-inducing peptide and use thereof |
| 05/07/2008 | EP1918296A2 New antitumoral compounds |
| 05/07/2008 | EP1917980A1 Use of a fusion protein between a cytokine and an antibody targeting the ED-B fibronectin domain for the treatment of atherosclerosis |
| 05/07/2008 | EP1917975A1 Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 05/07/2008 | EP1917974A1 Equine system for non-surgical artifical insemination |
| 05/07/2008 | EP1917973A1 Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof |
| 05/07/2008 | EP1917972A1 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 05/07/2008 | EP1917971A1 Substained release formulations comprising very low molecular weight polymers |
| 05/07/2008 | EP1917970A2 Hla binding peptides and their uses |
| 05/07/2008 | EP1917966A1 Agents and methods for protection treatment and repair of connective tissue |
| 05/07/2008 | EP1917960A1 Improved biological effects of rosmarinic acid |
| 05/07/2008 | EP1917355A2 Ply-gbs mutant lysins |
| 05/07/2008 | EP1917350A2 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
| 05/07/2008 | EP1917274A2 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1917040A2 Polyvalent vaccine |
| 05/07/2008 | EP1917039A2 Methods and compositions for regenerating articular cartilage |
| 05/07/2008 | EP1917037A2 Peg-ifn alpha and ribavirin for hbv treatment |
| 05/07/2008 | EP1917032A1 Use of a botulinum toxin to improve gastric emptying and/or to treat gerd |
| 05/07/2008 | EP1917028A2 Botulinum toxin in treatment of clubfoot relapse |
| 05/07/2008 | EP1917027A2 Cleavage of antifolate compounds |
| 05/07/2008 | EP1917026A1 Stimulators of factor x activated (fxa) as new topical antihemorrhagic agents |
| 05/07/2008 | EP1917025A2 Compositions comprising insulin and c-peptide for treating diabetes |
| 05/07/2008 | EP1917024A2 Methods of treating diseases with a vegf antagonist |
| 05/07/2008 | EP1917023A2 Erythropoietin receptor peptide formulations and uses |
| 05/07/2008 | EP1917022A2 Anti-tumor agents comprising r-spondins |
| 05/07/2008 | EP1917021A2 Methods for the treatment of anxiety and for identification of anxiolytic agents |
| 05/07/2008 | EP1917020A1 Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
| 05/07/2008 | EP1917006A2 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease |
| 05/07/2008 | EP1916997A2 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 05/07/2008 | EP1814566A4 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
| 05/07/2008 | EP1812467B1 PEPTIDES ABLE TO DISRUPT THE m-p53/p63, m-p53/ p73 AND m-p53/RESPECTIVE ISOFORM PROTEIN COMPLEXES FORMED IN TUMOR CELLS AND USES THEREOF IN PHARMACOLOGY |
| 05/07/2008 | EP1758923B8 Peptide substance restoring myocardium function |
| 05/07/2008 | EP1758922B8 Peptide substance restoring function of respiratory organs |
| 05/07/2008 | EP1701736A4 Therapeutic agents and uses therefor |
| 05/07/2008 | EP1649036B1 Method for producing cyclic molecules |
| 05/07/2008 | EP1603596B1 Liquid formulations of tumor necrosis factor-binding protein tbp-1 |
| 05/07/2008 | EP1592446B1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/07/2008 | EP1590366B1 Peptidic sulfonamides |
| 05/07/2008 | EP1575608B1 Use of cc-chemokine ccl5/rantes mutants against liver diseases |
| 05/07/2008 | EP1569960B1 Expression vector for dimeric interleukines |
| 05/07/2008 | EP1566386B1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 05/07/2008 | EP1545602B1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 05/07/2008 | EP1528931B1 Dipeptidyl peptidase iv inhibitors for decreasing the rate of chronic weight gain |
| 05/07/2008 | EP1509250B1 Methods compositions and articles of manufacture for modulating bone growth |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1456651B1 Self-assembly molecules |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1417308B1 Human protooncogene kg-20 and protein encoded therein |
| 05/07/2008 | EP1385531B1 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP1364026B1 Human g protein-coupled receptor |
| 05/07/2008 | EP1360208B1 Method for the production of cytotoxic anti-cancer antibodies |
| 05/07/2008 | EP1294903B1 Regulation of human transmembrane serine protease |
| 05/07/2008 | EP1141306B1 Streptococcus antigens |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | EP1129187B1 New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs |
| 05/07/2008 | EP1126028B1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/07/2008 | EP1059929B1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | EP0956299B1 Peptide antagonists of dp transcription factors |
| 05/07/2008 | CN101175855A Anti-MUC1 a/ss antibodies |
| 05/07/2008 | CN101175770A Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/07/2008 | CN101175766A Albumin solution |
| 05/07/2008 | CN101175507A Use of rip in treating staphylococcus aureus infections |
| 05/07/2008 | CN101175504A Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 05/07/2008 | CN101175478A Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 05/07/2008 | CN101173922A Gpr54 knock-out mammals and screening methods using them |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101173285A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/07/2008 | CN101173281A Rhabdophis tigrinus uncoupling protein gene -SA and uses thereof |
| 05/07/2008 | CN101173279A SCIRR69 gene, regulation BDNF transcription and application in biomedicine research, biological therapeutic research and invention |
| 05/07/2008 | CN101173270A Method for improving secernment efficiency of recombined protein |